WG3 – Clinical translation
Working Group 3 focusses on fostering cross-border information exchange about past and current clinical trials and studies of glioma.
Specific aims:
- Create a European-wide overview of studies of glioma diagnostics and follow-up from all Action Participants’ institutes.
- Coordinate the submission of joint grant applications to national, European, and international funding bodies (e.g. Marie Skłodowska-Curie Actions of the European Commission) for retrospective and prospective studies.
- Stimulate development of advanced and patient-friendly MRI-programs for clinical settings to gather prospective glioma imaging data.
Working Group Leaders:
Dr. Jan Petr (Leader) & Dr. Vera Keil (Vice-Leader)
If you would like to join WG3 or have any further questions, please contact glimr.cost.wg3@gmail.com.
